We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$9.24B
AUM Growth
-$130M
Cap. Flow
-$190M
Cap. Flow %
-2.05%
Top 10 Hldgs %
12.25%
Holding
362
New
11
Increased
110
Reduced
214
Closed
15

Top Buys

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$43.2M
2
TXT icon
Textron
TXT
+$33.4M
3
CF icon
CF Industries
CF
+$30.1M
4
MMSI icon
Merit Medical Systems
MMSI
+$30M
5
GBCI icon
Glacier Bancorp
GBCI
+$28.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$61M
2
ESNT icon
Essent Group
ESNT
+$38.1M
3
AGN
Allergan plc
AGN
+$35.4M
4
EME icon
Emcor
EME
+$28.2M
5
CVX icon
Chevron
CVX
+$27.8M

Sector Composition

Rank Sector Weight
1 Financials 17.58%
2 Industrials 14.58%
3 Healthcare 12.79%
4 Technology 11.13%
5 Consumer Discretionary 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
326
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$713K 0.01%
2,402
-6,162
-72% -$1.82M
PPBI
327
DELISTED
Pacific Premier Bancorp
PPBI
$648K 0.01%
20,779
-238
-1% -$7.23K
PTCT icon
328
PTC Therapeutics
PTCT
$6.23B
$647K 0.01%
19,140
+2,043
+12% +$88.9K
STE icon
329
Steris
STE
$23.3B
$618K 0.01%
4,274
-3,146
-42% -$470K
AVNS
330
DELISTED
Avanos Medical
AVNS
$616K 0.01%
16,448
-187
-1% -$7.13K
ESPR
331
DELISTED
Esperion Therapeutics
ESPR
$596K 0.01%
16,247
-149
-0.9% -$5.9K
LH icon
332
Labcorp
LH
$26.1B
$592K 0.01%
4,098
-191
-4% -$27.9K
PEG icon
333
Public Service Enterprise Group
PEG
$37.2B
$587K 0.01%
9,445
+2
+0% +$119
MXL icon
334
MaxLinear
MXL
$6.21B
$584K 0.01%
26,073
-300
-1% -$6.64K
ZTS icon
335
Zoetis
ZTS
$30.9B
$563K 0.01%
4,520
-228
-5% -$27.5K
PETQ
336
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$549K 0.01%
+20,122
New +$637K
BMY icon
337
Bristol-Myers Squibb
BMY
$132B
$534K 0.01%
10,521
+2,015
+24% +$94.7K
EBAY icon
338
eBay
EBAY
$47.9B
$500K 0.01%
12,828
-461
-3% -$18.5K
MTDR icon
339
Matador Resources
MTDR
$6.46B
$491K 0.01%
29,677
-339
-1% -$5.67K
RVNC
340
DELISTED
Revance Therapeutics, Inc.
RVNC
$456K ﹤0.01%
35,057
+7,636
+28% +$93.4K
BNY
341
Bank of New York Mellon
BNY
$108B
$455K ﹤0.01%
10,055
-480
-5% -$21.4K
AMGN icon
342
Amgen
AMGN
$226B
$319K ﹤0.01%
1,650
-50
-3% -$9.6K
HD icon
343
Home Depot
HD
$350B
$294K ﹤0.01%
1,269
– –
PH icon
344
Parker-Hannifin
PH
$134B
$284K ﹤0.01%
1,573
-94,907
-98% -$16.1M
NUE icon
345
Nucor
NUE
$62.5B
$245K ﹤0.01%
4,808
-223
-4% -$11.6K
GOOG icon
346
Alphabet (Google) Class C
GOOG
$4.35T
$244K ﹤0.01%
4,000
– –
LULU icon
347
lululemon athletica
LULU
$14.5B
$238K ﹤0.01%
1,238
– –
IWN icon
348
iShares Russell 2000 Value ETF
IWN
$14.5B
$237K ﹤0.01%
+1,987
New +$235K
XOM icon
349
ExxonMobil
XOM
$657B
$217K ﹤0.01%
3,084
– –
ADEA icon
350
Adeia
ADEA
$3.07B
– –
-861,761
Closed -$4.69M
11 12 13
14
15

Similar funds

GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Rothschild & Co Asset Management US's Q3 2019 Portfolio in Review

As of Q3 2019, Rothschild & Co Asset Management US held 362 positions worth $9.24B, down 1.4% from $9.37B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Rothschild & Co Asset Management US's Q3 2019 filing shows 11 new, 110 increased, 214 reduced and 15 closed positions. Its largest new stake was Kimberly-Clark: 314,002 shares worth $44.6M. The largest sale was Pfizer, an estimated $61M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Rothschild & Co Asset Management US's largest Q3 2019 buy was Kimberly-Clark: 314,002 shares worth $44.6M.
  • Rothschild & Co Asset Management US added most to Merit Medical Systems in Q3 2019, an estimated $30M increase.
  • Rothschild & Co Asset Management US's biggest Q3 2019 reduction was Pfizer, cutting an estimated $61M.
  • Rothschild & Co Asset Management US fully exited Essent Group in Q3 2019, selling an estimated $38.1M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 12% of its $9.24B portfolio in Q3 2019.
  • Rothschild & Co Asset Management US opened 11 new positions and closed 15 in Q3 2019.
  • Rothschild & Co Asset Management US's portfolio value fell 1.4% quarter-over-quarter to $9.24B.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2019, filed 8 Nov 2019.